ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
2690Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 47,648 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 1.67% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 384 shares, the number of shares held decreased 0.92% compared to the previous period and now represents 0.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 248 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 0.91% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 1,296 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 1.03% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 1,768 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 2.26% of the total position.
ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 11,968 shares, the number of shares held increased 0.75% compared to the previous period and now represents 2.39% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 34,200 shares, the number of shares held decreased 1.06% compared to the previous period and now represents 2.38% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 424 shares, the number of shares held decreased 0.93% compared to the previous period and now represents 1.12% of the total position.
ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 31,536 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 1.15% of the total position.
ARKG Investment Tracker position change: Decreased position in Illumina by 3,968 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 4.46% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 104,624 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 1.87% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 21,240 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 2.69% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 111,256 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 4.19% of the total position.
ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 18,346 shares, the number of shares held increased 0.95% compared to the previous period and now represents 2.77% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 10,488 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 3.64% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 31,352 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 4.26% of the total position.
ARKG Investment Tracker position change: Decreased position in CareDx by 20,320 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 3.31% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 4,728 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 3.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 2,368 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 4.5% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 21,392 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 4.84% of the total position.
Go to Tiger App to see more news